Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease. uri icon

authors

  • Wang, Guoqiao
  • Libre-Guerra, Jorge J
  • Shi, Xinyu
  • Mummery, Catherine J
  • van Dyck, Christopher H
  • Lah, James J
  • Honig, Lawrence S
  • Day, Gregg
  • Ringman, John M
  • Brooks, William S
  • Fox, Nick C
  • Li, Yan
  • Suzuki, Kazushi
  • Levin, Johannes
  • Jucker, Mathias
  • Delmar, Paul
  • Bittner, Tobias
  • Bateman, Randall J
  • Xiong, Chengjie
  • Benzinger, Tammie L S
  • Gordon, Brian A
  • Hassenstab, Jason
  • Andrew Aschenbrenner, PhD
  • McDade, Eric
  • Clifford, David B

publication date

  • February 23, 2024